No one is making goal

Discussion in 'Avanir Pharmaceuticals' started by anonymous, Jul 14, 2018 at 9:57 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Some reps made over 20K for Q3
    bonus, not bad.
     

  2. anonymous

    anonymous Guest

    Take it as a severance. Sad days ahead.
     
  3. anonymous

    anonymous Guest

    Do Tell .....
     
  4. anonymous

    anonymous Guest

    They announced National meeting in LA
    In March, so I doubt any layoffs would be before then, so hopefully we’re good till at least mid March 2019
     
  5. anonymous

    anonymous Guest

    Noone is getting laid off. Stop listening to the negative Nellys and do your job. This is a great place to be right now.
     
  6. anonymous

    anonymous Guest

    What about the remaining lasrs? I have one in my region and she’s shitting her pants.
     
  7. anonymous

    anonymous Guest

    Another quarter and no bonus
     
  8. anonymous

    anonymous Guest

    Some reps made over 20K for
    the quarter paid out today :)
     
  9. anonymous

    anonymous Guest

    Only 43% of the territories are making their Nuedexta goal

    Every week the nation is dropping
     
  10. anonymous

    anonymous Guest

    No way is the avg bonus payout
    40K a year like they claim that’s the target bonus
     
  11. anonymous

    anonymous Guest

     
  12. anonymous

    anonymous Guest

    You are right

    $40,000 is the target bonus

    Most NAM’s are not making anything close to that

    Most are making ZERO bonus and ZERO raises
     
  13. anonymous

    anonymous Guest

    And

    Most NAM’s are not making the $40,000
    Target Bonus for the year that is dangled
    During the interview process

    Only come to Avanir if you really need a job

    Avanir has a very high turnover rate
     
  14. anonymous

    anonymous Guest

    Only 40 NAMS now making their baseline
     
  15. anonymous

    anonymous Guest

    Managed Care Coverage is starting
    to kill everyone
     
  16. anonymous

    anonymous Guest

    Out of how many?
     
  17. anonymous

    anonymous Guest

    Bottom line everyone.

    Avanir was a great place to work from 2011-2016, nuedexta was flying off the shelf and reps made out on being acquired from Otsuka making anywhere from $17 a share to $10 a share after sale. 1/2 the sales force was making 20k a quarter.

    I had the privaledge of trying to sell the blockbuster Nonzentra.
    Onzentra has had most likely the worst insurance coverage I have seen in my 15 year pharmaceutical career and it was a M2.

    Nuedexta will never get the agitation indication. Why would a company spend billions of dollars when HCPs use it off label already.

    I left in 2017 and got a job in oncology and it was the best move I ever made.

    To those who are being complacent you should be getting your resume ready to get out of there. If you wait around to long when the ship sinks you will have nothing. Avanir cannot keep operating when sales plummet every quarter.

    Get out while you can.
     
  18. anonymous

    anonymous Guest

    They said we should get the agitation indication in the next two years ,
    and it’s a different formulation than
    the current Nuedexta.
     
  19. anonymous

    anonymous Guest

    Out of 100
    40 making goal or the Target bonus
    of 10K for Q4
     
  20. anonymous

    anonymous Guest


    You must not be in the knowing. There is big news to come out on that new formulation. Your 2 year plan is more like 5 year plan. I wish it weren’t true....

    #hydrogenatomisnotquinidine